Sign in
4

Changes in Ownership

Annexon, Inc. Filed Acc 0001567619-21-007133

EVP & Chief Scientific Officer sold 16,175 shares at an average $28.80 ($465,770)

  • EVP & Chief Scientific Officer acquired 16,175 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Yednock Ted · EVP & Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-25 Exercise or conversion : show line 1 in the form +15,000 $1.41 $21,144 15,000 D
2021-03-25 Exercise or conversion : show line 2 in the form +1,175 $5.11 $6,004 16,175 D
2021-03-25 Sale : show line 3 in the form −10,258 $28.54 $292,755 5,917 D
2021-03-25 Sale : show line 4 in the form −5,680 $29.21 $165,914 237 D
2021-03-25 Sale : show line 5 in the form −237 $29.96 $7,101 0 D
Open-market sales · 16,175 sh · avg $28.80 · $465,770

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-25 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −15,000 40,615 D
2021-03-25 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −1,175 69,129 D
Loading xslF345X03/doc1.xml…